Fibrocytes are associated with the fibrosis of coronary heart disease

Pathology Research and Practice

Volumn 209, Issue 1, 2013, Pages 36-43

  Lei, Pu Ping ^a   Qu, Yong Qiang ^a   Shuai, Qun ^b   Tao, Si Ming ^a   Bao, Yu Xia ^a   Wang, Yu ^a   Wang, Shang Wen ^a   Wang, Dian Hua ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b Yunnan Police College   (China)

Author keywords

SMA; Cardiac fibrosis; CHD; Coronary heart disease; ECM; Fibrocytes; Human; SDF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CHEMOKINE RECEPTOR CXCR4; PROCOLLAGEN C PROTEINASE; STROMAL CELL DERIVED FACTOR 1;

ADULT; ARTICLE; BIOTINYLATION; BONE MARROW CELL; CELL POPULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FIBROCYTE; HEART MUSCLE FIBROSIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; MALE; PROTEIN ANALYSIS; PROTEIN LOCALIZATION;

CHEMOKINE CXCL1; CORONARY DISEASE; FEMALE; FIBROBLASTS; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; RECEPTORS, CXCR4;

EID: 84872372947     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2012.09.012     Document Type: Article

References (34)

1. Carter-Monroe N., Virmani R. Current trends in the classification of sudden cardiac death based on autopsy derived data: a review of investigations into the etiology of sudden cardiac death. Rev. Esp. Cardiol. 2011, 64:10-12.
2. Franco M., Cooper R., Bilal U., Fuster V. Control of coronary heart disease risk factors and evidence-based therapies: joint efforts for coronary heart disease prevention in Spain. Rev. Esp. Cardiol. 2011, 64:962-964.
3. Frangogiannis N.G. The immune system and cardiac repair. Pharmacol. Res. 2008, 58:88-111.
4. Mias C., Lairez O., Trouche E., Roncalli J., Calise D., Seguelas M.H., Ordener C., Piercecchi-Marti M.D., Auge N., Salvayre A.N., Bourin P., Parini A., Cussac D. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 2009, 27:2734-2743.
5. Krenning G., Zeisberg E.M., Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J. Cell. Physiol. 2010, 225:631-637.
6. Quan T.E., Cowper S., Wu S.P., Bockenstedt L.K., Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int. J. Biochem. Cell Biol. 2004, 36:598-606.
7. Andersson-Sjoland A., de Alba C.G., Nihlberg K., Becerril C., Ramirez R., Pardo A., Westergren-Thorsson G., Selman M. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int. J. Biochem. Cell Biol. 2008, 40:2129-2140.
8. Strieter R.M., Gomperts B.N., Keane M.P. The role of CXC chemokines in pulmonary fibrosis. J. Clin. Invest. 2007, 117:549-556.
9. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., Giordano F.J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004, 110:3300-3305.
10. Haudek S.B., Xia Y., Huebener P., Lee J.M., Carlson S., Crawford J.R., Pilling D., Gomer R.H., Trial J., Frangogiannis N.G., Entman M.L. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18284-18289.
11. Chu P.Y., Mariani J., Finch S., McMullen J.R., Sadoshima J., Marshall T., Kaye D.M. Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am. J. Pathol. 2010, 176:1735-1742.
12. Rosin N.L., Sopel M., Falkenham A., Myers T.L., Legare J.F. Myocardial migration by fibroblast progenitor cells is blood pressure dependent in a model of angII myocardial fibrosis. Hypertens. Res. 2012, 35:449-456.
13. Sopel M., Falkenham A., Oxner A., Ma I., Lee T.D., Legare J.F. Fibroblast progenitor cells are recruited into the myocardium prior to the development of myocardial fibrosis. Int. J. Exp. Pathol. 2012, 93:115-124.
14. Mendis S., Thygesen K., Kuulasmaa K., Giampaoli S., Mahonen M., Ngu Blackett K., Lisheng L. World Health Organization definition of myocardial infarction: 2008-09 revision. Int. J. Epidemiol. 2011, 40:139-146.
15. Berk B.C., Fujiwara K., Lehoux S. ECM remodeling in hypertensive heart disease. J. Clin. Invest. 2007, 117:568-575.
16. Eghbali M., Weber K.T. Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression. Mol. Cell. Biochem. 1990, 96:1-14.
17. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., Gabbiani G. The myofibroblast: one function, multiple origins. Am. J. Pathol. 2007, 170:1807-1816.
18. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214:199-210.
19. Murdoch C. CXCR4: chemokine receptor extraordinaire. Immunol. Rev. 2000, 177:175-184.
20. Frid M.G., Brunetti J.A., Burke D.L., Carpenter T.C., Davie N.J., Reeves J.T., Roedersheimer M.T., van Rooijen N., Stenmark K.R. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am. J. Pathol. 2006, 168:659-669.
21. Kisseleva T., Uchinami H., Feirt N., Quintana-Bustamante O., Segovia J.C., Schwabe R.F., Brenner D.A. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 2006, 45:429-438.
22. Moore B.B., Murray L., Das A., Wilke C.A., Herrygers A.B., Toews G.B. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am. J. Respir. Cell Mol. Biol. 2006, 35:175-181.
23. Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., Belperio J.A., Keane M.P., Strieter R.M. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 2004, 114:438-446.
24. Moeller A., Gilpin S.E., Ask K., Cox G., Cook D., Gauldie J., Margetts P.J., Farkas L., Dobranowski J., Boylan C., O'Byrne P.M., Strieter R.M., Kolb M. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009, 179:588-594.
25. Wang C.H., Huang C.D., Lin H.C., Lee K.Y., Lin S.M., Liu C.Y., Huang K.H., Ko Y.S., Chung K.F., Kuo H.P. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am. J. Respir. Crit. Care Med. 2008, 178:583-591.
26. LaPar D.J., Burdick M.D., Emaminia A., Harris D.A., Strieter B.A., Liu L., Robbins M., Kron I.L., Strieter R.M., Lau C.L. Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker. Ann. Thorac. Surg. 2011, 92:470-477. (discussion 477).
27. Saunders R., Siddiqui S., Kaur D., Doe C., Sutcliffe A., Hollins F., Bradding P., Wardlaw A., Brightling C.E. Fibrocyte localization to the airway smooth muscle is a feature of asthma. J. Allergy Clin. Immunol. 2009, 123:376-384.
28. Galan A., Cowper S.E., Bucala R. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Curr. Opin. Rheumatol. 2006, 18:614-617.
29. Yang L., Scott P.G., Dodd C., Medina A., Jiao H., Shankowsky H.A., Ghahary A., Tredget E.E. Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen. 2005, 13:398-404.
30. Ishida Y., Kimura A., Takayasu T., Eisenmenger W., Kondo T. Detection of fibrocytes in human skin wounds and its application for wound age determination. Int. J. Legal Med. 2009, 123:299-304.
31. Garcia-De-Alba C., Becerril C., Ruiz V., Gonzalez Y., Reyes S., Garcia-Alvarez J., Selman M., Pardo A. Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. Am. J. Respir. Crit. Care Med. 2010, 182:1144-1152.
32. Strieter R.M., Keeley E.C., Burdick M.D., Mehrad B. The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis. Trans. Am. Clin. Climatol. Assoc. 2009, 120:49-59.
33. Quan T.E., Cowper S.E., Bucala R. The role of circulating fibrocytes in fibrosis. Curr. Rheumatol. Rep. 2006, 8:145-150.
34. + fibrocytes in normal mitral valves and myxomatous mitral valve degeneration. Pathol. Res. Pract. 2005, 201:301-304.